Ryke Geerd Hamer

For my international readers, it's a holiday here in the U.S. That means I plan on taking it easy, which means I've decided on doing, in essence, a "rerun." I chose this particular rerun based on my post from last Thursday. I thought that rerunning this particular post is a good reminder of what the cost of eschewing science-based therapy for breast cancer can be, and that price is horrible. This particular post dates back to 2006; so, if you haven't been reading the awesomeness that is my blog that long, it's new to you. I'll be back with new Insolence tomorrow. I've written before about how…